Elke de Boer, Charlotte W Ockeloen, Rosalie A Kampen, Juliet E Hampstead, Alexander J M Dingemans, Dmitrijs Rots, Lukas Lütje, Tazeen Ashraf, Rachel Baker, Mouna Barat-Houari, Brad Angle, Nicolas Chatron, Anne-Sophie Denommé-Pichon, Orrin Devinsky, Christèle Dubourg, Frances Elmslie, Houda Zghal Elloumi, Laurence Faivre, Sarah Fitzgerald-Butt, David Geneviève, Jacqueline A C Goos, Benjamin M Helm, Usha Kini, Amaia Lasa-Aranzasti, Gaetan Lesca, Sally A Lynch, Irene M J Mathijssen, Ruth McGowan, Kristin G Monaghan, Sylvie Odent, Rolph Pfundt, Audrey Putoux, Jeroen van Reeuwijk, Gijs W E Santen, Erina Sasaki, Arthur Sorlin, Peter J van der Spek, Alexander P A Stegmann, Sigrid M A Swagemakers, Irene Valenzuela, Eléonore Viora-Dupont, Antonio Vitobello, Stephanie M Ware, Mathys Wéber, Christian Gilissen, Karen J Low, Simon E Fisher, Lisenka E L M Vissers, Maggie M K Wong, Tjitske Kleefstra
PURPOSE: Although haploinsufficiency of ANKRD11 is among the most common genetic causes of neurodevelopmental disorders, the role of rare ANKRD11 missense variation remains unclear. We characterized clinical, molecular, and functional spectra of ANKRD11 missense variants. METHODS: We collected clinical information of individuals with ANKRD11 missense variants and evaluated phenotypic fit to KBG syndrome. We assessed pathogenicity of variants through in silico analyses and cell-based experiments...
July 13, 2022: Genetics in Medicine: Official Journal of the American College of Medical Genetics